Bromobenzene

Bromobenzene

SCHEMBL2158200

Brc1ccccc1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromobenzene SCHEMBL1542 1.00
Bromobenzene SCHEMBL537562 1.00 ALDH1A1 (1.00)
Bromobenzene SCHEMBL1331681 1.00
Bromobenzene SCHEMBL1332317 1.00
Bromobenzene SCHEMBL1331176 1.00
Bromobenzene SCHEMBL20537325 1.00 ALDH1A1 (1.00)
SCHEMBL24508036 0.96 ALDH1A1 (0.92)
Bromobenzene SCHEMBL313507 0.96 ALDH1A1 (0.92)
Bromobenzene SCHEMBL22390537 0.96
Bromobenzene SCHEMBL11077625 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742915-A2 TETRAHYDROPYRANYL CYCLOPENTYL TETRAHY-DROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2007-01-17 EP claimed
WO-2005120505-A2 TETRAHYDROPYRANYL CYCLOPENTYL TETRAHY-DROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC (US) 2005-12-22 WO claimed
CN-104666292-B Medicine for treating cervical and lumbar diseases 刘力 2020-02-18 CN disclosed
EP-2941420-A1 (4E)-4-(4-SUBSTITUTED BENZYLIDENEAMINO)-2,3-DIHYDRO-3- SUBSTITUTED-2-THIOXOTHIAZOLE-5-CARBONITRILES AS A2AR ANTAGONIST AND PROCESS FOR PREPARATION THEREOF Council of Scientific & Industrial Research (IN) 2015-11-11 EP disclosed
WO-2014106861-A1 (4E)-4-(4-SUBSTITUTED BENZYLIDENEAMINO)-2,3-DIHYDRO-3- SUBSTITUTED-2-THIOXOTHIAZOLE-5-CARBONITRILES AS A2AR ANTAGONIST AND PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-07-10 WO disclosed
US-8378050-B2 Linear and cross-linked high molecular weight polysilanes, polygermanes, and copolymers thereof, compositions containing the same, and methods of making and using such compounds and compositions KOVIO, INC. (US) 2013-02-19 US disclosed
US-20110183502-A1 Linear and Cross-Linked High Molecular Weight Polysilanes, Polygermanes, and Copolymers Thereof, Compositions Containing the Same, and Methods of Making and Using Such Compounds and Compositions ENSURGE MICROPOWER ASA 2011-07-28 US disclosed
CN-100460377-C Process for preparation of cyclohexanol derivatives YANTAI VALIANT FINE CHEMICALS (CN) 2009-02-11 CN disclosed
EP-1943669-A2 LINEAR AND CROSS-LINKED HIGH MOLECULAR WEIGHT POLYSILANES, POLYGERMANES, AND COPOLYMERS THEREOF, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF MAKING AND USING SUCH COMPOUNDS AND COMPOSITIONS Nanogram Corporation (US) 2008-07-16 EP disclosed
WO-2007044429-A2 LINEAR AND CROSS-LINKED HIGH MOLECULAR WEIGHT POLYSILANES, POLYGERMANES, AND COPOLYMERS THEREOF, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF MAKING AND USING SUCH COMPOUNDS AND COMPOSITIONS NANOGRAM CORPORATION (US) 2007-04-19 WO disclosed
US-20070078252-A1 Linear and cross-linked high molecular weight polysilanes, polygermanes, and copolymers thereof, compositions containing the same, and methods of making and using such compounds and compositions ENSURGE MICROPOWER ASA 2007-04-05 US disclosed
CN-1923778-A Cyclohexanol derivative, cyclohexanone derivative and preparation method VALIANT FINE CHEMICALS CO LTD (CN) 2007-03-07 CN disclosed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed